Global Neuroprosthetics Market - Technologies, Market share and Industry Forecast to 2024

  • ID: 4542279
  • Report
  • Region: Global
  • 190 Pages
  • Occams Business Research and Consulting
1 of 4

FEATURED COMPANIES

  • Cyberonics Inc. (U.S.)
  • Livanova Plc (UK)
  • Med-El (Austria)
  • Medtronic Plc (U.S.)
  • NDI Medical Llc (U.S.)
  • Neuropace Inc. (U.S.)
  • MORE

Global neuroprosthetics market is expected to grow at a CAGR of 12.7% during forecast period 2017-2024. The key factor driving the market growth are increasing number of patients suffering from neurological disorders and nerve injury, increasing incidence of hearing loss, increasing cases of amputation due to the rising number of accidents & injuries and increasing prevalence of diabetes. However, availability of alternative treatment options and high cost of neuroprosthetics are expected to restrain the market growth. Higher growth opportunities in emerging economies and advances in neuroprosthetic implantation are expected to provide lucrative market opportunities. Factors such as unfavorable reimbursement scenario and lack of trained professionals are expected to challenge the market growth.

North America is the dominating market region in terms of market revenue share. The key factors driving the market growth in North America are growing healthcare industry, supportive government policies, rising geriatric population, and availability of advanced technologies. Also there has been presence of leading market players such as Abbott laboratories, Boston Scientific, Medtronic, NDI Medical, etc. in North America boosting the growth of neuroprosthetics market in the region. However, Asia Pacific is expected to emerge as the fastest growing market region during forecast period. This is due to the developing healthcare infrastructure, increasing medical tourism in India, China etc., supportive funding for the launch of novel neuroprosthetics products, and rising prevalence of neurological disorders in the Asia Pacific region. Moreover, rising awareness among patients and increasing hearing-related problems, rising government funding for the development of healthcare infrastructure and services is contributing significantly to Asia-Pacific neuroprosthetics market.

The report on global neuroprosthetics market includes type, technique and application. On the basis of type segment, market is segregated into output neural prosthetics and input neural prosthetics. Output neural prosthetics is further segmented into motor prosthetics and cognitive prosthetics. Input neural prosthetics is further segmented into cochlear implants and bionic eye/retinal implants. Input neural prosthetics is the dominating segment owing to the rising prevalence of hearing loss which has led to the increased adoption of input neural prosthetics such as cochlear implants, etc. On the basis of techniques, market is bifurcated into spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation and transcranial magnetic stimulation. Spinal cord stimulation is the leading technique segment due to the rising number of patients suffering from back surgery syndrome, chronic back pain, Ischemia, etc. Whereas, applications of neuroprosthetics include motor neuron disorders, physiological disorders and cognitive disorders. Motor neuron disorder is further segmented into Parkinson’s disease and Epilepsy. Physiological Disorders is further segmented into auditory processing disorders, ophthalmic disorders, cardiovascular disorders and urology disorders. Cognitive Disorders is further segmented into Alzheimer’s disease and Paralysis. Physiological disorder is the dominating application segment owing to the increased adoption of neuroprosthetics for the treatment of physiological disorders.

Global neuroprosthetics market is positively influenced by the presence of leading market players, such as Sonova Holding AG (Switzerland), St. Jude Medical Inc. (U.S), Medtronic PLC (U.S), Boston Scientific Corporation (U.S), Cochlear Limited (Australia), etc. Product launch, joint venture, merger and acquisition are some of the crucial strategies adopted by the key market players to gain competitive advantage.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cyberonics Inc. (U.S.)
  • Livanova Plc (UK)
  • Med-El (Austria)
  • Medtronic Plc (U.S.)
  • NDI Medical Llc (U.S.)
  • Neuropace Inc. (U.S.)
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology

2. Market Overview
2.1. Global Neuroprosthetics Market: Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360-Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Key Strategies & Analysis
2.8.2. Market Share Analysis & Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities In Emerging Applications
2.9.3. Investment Opportunity In Fastest Growing Segment

3. Market Determinants
3.1. Market Drivers
3.1.1. Increasing Prevalence Of Neurological Disorders And Nerve Injury
3.1.2. Increasing Incidence Of Hearing Loss
3.1.3. Increasing Cases Of Amputation Due To The Rising Number Of Accidents & Injuries
3.1.4. Increasing Prevalence Of Diabetes
3.2. Market Restraints
3.2.1. Availability Of Alternative Treatment Options
3.2.2. High Cost Of Neuroprosthetics
3.3. Market Opportunities
3.3.1. Higher Growth Opportunities In Emerging Economies
3.3.2. Advances In Neuroprosthetic Implantation
3.4. Market Challenges
3.4.1. Unfavorable Reimbursement Scenario
3.4.2. Lack Of Trained Professionals

4. Market Segmentation
4.1. Global Neuroprosthetics Market By Type
4.1.1. Market Definition And Scope
4.1.2. Decision Support Database & Estimation Methodology
4.1.3. Comparative Analysis Across Market Segments
4.1.4. Opportunity Matrix
4.1.5. Market Segmentation
4.1.5.1. Global Output Neural Prosthetics Market
4.1.5.1.1. Adoption Scenario & Market Determinants
4.1.5.1.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.1.5.1.3. Key Players & Key Products
4.1.5.1.4. Key Conclusions
4.1.5.1.5. Market Sub-Segments
4.1.5.1.5.1. Motor Prosthetics
4.1.5.1.5.2. Cognitive Prosthetics
4.1.5.2. Global Input Neural Prosthetics Market
4.1.5.2.1. Adoption Scenario & Market Determinants
4.1.5.2.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.1.5.2.3. Key Players & Key Products
4.1.5.2.4. Key Conclusions
4.1.5.2.5. Market Sub-Segments
4.1.5.2.5.1. Cochlear Implants
4.1.5.2.5.2. Bionic Eye/Retinal Implants
4.2. Global Neuroprosthetics Market By Technique
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4. Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Global Spinal Cord Stimulation Market
4.2.5.1.1. Adoption Scenario & Market Determinants
4.2.5.1.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.2.5.1.3. Key Players & Key Products
4.2.5.1.4. Key Conclusions
4.2.5.2. Global Deep Brain Stimulation Market
4.2.5.2.1. Adoption Scenario & Market Determinants
4.2.5.2.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.2.5.2.3. Key Players & Key Products
4.2.5.2.4. Key Conclusions
4.2.5.3. Global Vagus Nerve Stimulation Market
4.2.5.3.1. Adoption Scenario & Market Determinants
4.2.5.3.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.2.5.3.3. Key Players & Key Products
4.2.5.3.4. Key Conclusions
4.2.5.4. Global Sacral Nerve Stimulation Market
4.2.5.4.1. Adoption Scenario & Market Determinants
4.2.5.4.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.2.5.4.3. Key Players & Key Products
4.2.5.4.4. Key Conclusions
4.2.5.5. Global Transcranial Magnetic Stimulation Market
4.2.5.5.1. Adoption Scenario & Market Determinants
4.2.5.5.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.2.5.5.3. Key Players & Key Products
4.2.5.5.4. Key Conclusions
4.3. Global Neuroprosthetics Market By Application
4.3.1. Market Definition And Scope
4.3.2. Decision Support Database & Estimation Methodology
4.3.3. Comparative Analysis Across Market Segments
4.3.4. Opportunity Matrix
4.3.5. Market Segmentation
4.3.5.1. Global Motor Neuron Disorders Market
4.3.5.1.1. Adoption Scenario & Market Determinants
4.3.5.1.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.3.5.1.3. Key Players & Key Products
4.3.5.1.4. Key Conclusions
4.3.5.1.5. Market Sub-Segments
4.3.5.1.5.1. Parkinson’S Disease
4.3.5.1.5.2. Epilepsy
4.3.6. Global Physiological Disorders Market
4.3.6.1. Adoption Scenario & Market Determinants
4.3.6.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.3.6.3. Key Players & Key Products
4.3.6.4. Key Conclusions
4.3.6.5. Market Sub-Segments
4.3.6.5.1. Auditory Processing Disorders
4.3.6.5.2. Ophthalmic Disorders
4.3.6.5.3. Cardiovascular Disorders
4.3.6.5.4. Urology Disorders
4.3.7. Global Cognitive Disorders Market
4.3.7.1. Adoption Scenario & Market Determinants
4.3.7.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.3.7.3. Key Players & Key Products
4.3.7.4. Key Conclusions
4.3.7.5. Market Sub-Segments
4.3.7.5.1. Alzheimer’S Disease
4.3.7.5.2. Paralysis

5. Competitive Landscape
5.1. Key Strategies
5.1.1. List Of Mergers And Acquisition
5.1.2. List Of Joint Ventures
5.1.3. List Of Product Launches
5.1.4. List Of Partnerships

6. Geographic Analysis
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4. Global Neuroprosthetics Market By Region 2015-2024
6.4.1. North America
6.4.1.1. Industry Analysis 2015-2024 ($ Million)
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.1.2.1.2. Key Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.1.2.2.2. Key Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Analysis 2015-2024 ($ Million)
6.4.2.2. Top Country Analysis
6.4.2.2.1. UK
6.4.2.2.1.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.2.2.1.2. Key Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.2.2.2.2. Key Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.2.2.3.2. Key Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Spain
6.4.2.2.4.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.2.2.4.2. Key Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.2.2.5. Rest Of Europe
6.4.2.2.5.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.2.2.5.2. Key Players & Key Products
6.4.2.2.5.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Analysis 2015-2024 ($ Million)
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.3.2.1.2. Key Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.3.2.2.2. Key Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.3.2.3.2. Key Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Australia
6.4.3.2.4.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.3.2.4.2. Key Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.3.2.5. Rest Of Asia Pacific
6.4.3.2.5.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.3.2.5.2. Key Players & Key Products
6.4.3.2.5.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Analysis 2015-2024 ($ Million)
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.4.2.1.2. Key Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2015-2024 ($ Million)
6.4.4.2.2.2. Key Players & Key Products
6.4.4.2.2.3. Key Conclusions

7. Company Profiles
7.1. Abbott Laboratories (U.S.)
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Strategic Initiatives
7.1.4. Scot Analysis
7.1.5. Strategic Analysis
7.2. Boston Scientific Corporation (U.S.)
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Strategic Initiatives
7.2.4. Scot Analysis
7.2.5. Strategic Analysis
7.3. Cochlear Limited (Australia)
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Strategic Initiatives
7.3.4. Scot Analysis
7.3.5. Strategic Analysis
7.4. Cyberonics Inc. (U.S.)
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Strategic Initiatives
7.4.4. Scot Analysis
7.4.5. Strategic Analysis
7.5. Livanova Plc (UK)
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Strategic Initiatives
7.5.4. Scot Analysis
7.5.5. Strategic Analysis
7.6. Med-El (Austria)
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Strategic Initiatives
7.6.4. Scot Analysis
7.6.5. Strategic Analysis
7.7. Medtronic Plc (U.S.)
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Strategic Initiatives
7.7.4. Scot Analysis
7.7.5. Strategic Analysis
7.8. NDI Medical Llc (U.S.)
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Strategic Initiatives
7.8.4. Scot Analysis
7.8.5. Strategic Analysis
7.9. Neuropace Inc. (U.S.)
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Strategic Initiatives
7.9.4. Scot Analysis
7.9.5. Strategic Analysis
7.10. Nevro (U.S.)
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Strategic Initiatives
7.10.4. Scot Analysis
7.10.5. Strategic Analysis
7.11. Retina Implant AG (Germany)
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Strategic Initiatives
7.11.4. Scot Analysis
7.11.5. Strategic Analysis
7.12. Second Sight (U.S.)
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Strategic Initiatives
7.12.4. Scot Analysis
7.12.5. Strategic Analysis
7.13. Sonova Holding AG (Switzerland)
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Strategic Initiatives
7.13.4. Scot Analysis
7.13.5. Strategic Analysis
7.14. St. Jude Medical Inc. (U.S.)
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Strategic Initiatives
7.14.4. Scot Analysis
7.14.5. Strategic Analysis
7.15. Zimmer Biomet (U.S.)
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Strategic Initiatives
7.15.4. Scot Analysis
7.15.5. Strategic Analysis

List Of Tables:
1. Global Neuroprosthetics Market By Type 2015-2024 ($ Million)
2. Global Output Neural Prosthetics Market By Geography 2015-2024 ($ Million)
3. Global Neuroprosthetics Market By Output Neural Prosthetics 2015-2024 ($ Million)
4. Global Input Neural Prosthetics Market By Geography 2015-2024 ($ Million)
5. Global Neuroprosthetics Market By Input Neural Prosthetics 2015-2024 ($ Million)
6. Global Neuroprosthetics Market By Technique 2015-2024 ($ Million)
7. Global Spinal Cord Stimulation Market By Geography 2015-2024 ($ Million)
8. Global Deep Brain Stimulation Market By Geography 2015-2024 ($ Million)
9. Global Vagus Nerve Stimulation Market By Geography 2015-2024 ($ Million)
10. Global Sacral Nerve Stimulation Market By Geography 2015-2024 ($ Million)
11. Global Transcranial Magnetic Stimulation Market By Geography 2015-2024 ($ Million)
12. Global Neuroprosthetics Market By Application 2015-2024 ($ Million)
13. Global Motor Neuron Disorders Market By Geography 2015-2024 ($ Million)
14. Global Neuroprosthetics Market By Motor Neuron Disorders 2015-2024 ($ Million)
15. Global Physiological Disorders Market By Geography 2015-2024 ($ Million)
16. Global Neuroprosthetics Market By Physiological Disorders 2015-2024 ($ Million)
17. Global Cognitive Disorders Market By Geography 2015-2024 ($ Million)
18. Global Neuroprosthetics Market By Cognitive Disorders 2015-2024 ($ Million)
19. North America Neuroprosthetics Market 2015-2024 ($ Million)
20. Europe Neuroprosthetics Market 2015-2024 ($ Million)
21. Asia Pacific Neuroprosthetics Market 2015-2024 ($ Million)
22. Rest Of The World Neuroprosthetics Market 2015-2024 ($ Million)
23. North America Neuroprosthetics Market By Type 2015-2024 ($ Million)
24. Europe Neuroprosthetics Market By Type 2015-2024 ($ Million)
25. Asia Pacific Neuroprosthetics Market By Type 2015-2024 ($ Million)
26. Rest Of The World Neuroprosthetics Market By Type 2015-2024 ($ Million)
27. North America Neuroprosthetics Market By Technique 2015-2024 ($ Million)
28. Europe Neuroprosthetics Market By Technique 2015-2024 ($ Million)
29. Asia Pacific Neuroprosthetics Market By Technique 2015-2024 ($ Million)
30. Rest Of The World Neuroprosthetics Market By Technique 2015-2024 ($ Million)
31. North America Neuroprosthetics Market By Application 2015-2024 ($ Million)
32. Europe Neuroprosthetics Market By Application 2015-2024 ($ Million)
33. Asia Pacific Neuroprosthetics Market By Application 2015-2024 ($ Million)
34. Rest Of The World Neuroprosthetics Market By Application 2015-2024 ($ Million)
35. United States Neuroprosthetics Market By Type 2015-2024 ($ Million)
36. United States Neuroprosthetics Market By Technique 2015-2024 ($ Million)
37. United States Neuroprosthetics Market By Application 2015-2024 ($ Million)
38. Canada Neuroprosthetics Market By Type 2015-2024 ($ Million)
39. Canada Neuroprosthetics Market By Technique 2015-2024 ($ Million)
40. Canada Neuroprosthetics Market By Application 2015-2024 ($ Million)
41. UK Neuroprosthetics Market By Type 2015-2024 ($ Million)
42. UK Neuroprosthetics Market By Technique 2015-2024 ($ Million)
43. UK Neuroprosthetics Market By Application 2015-2024 ($ Million)
44. Germany Neuroprosthetics Market By Type 2015-2024 ($ Million)
45. Germany Neuroprosthetics Market By Technique 2015-2024 ($ Million)
46. Germany Neuroprosthetics Market By Application 2015-2024 ($ Million)
47. France Neuroprosthetics Market By Type 2015-2024 ($ Million)
48. France Neuroprosthetics Market By Technique 2015-2024 ($ Million)
49. France Neuroprosthetics Market By Application 2015-2024 ($ Million)
50. Spain Neuroprosthetics Market By Type 2015-2024 ($ Million)
51. Spain Neuroprosthetics Market By Technique 2015-2024 ($ Million)
52. Spain Neuroprosthetics Market By Application 2015-2024 ($ Million)
53. Roe Neuroprosthetics Market By Type 2015-2024 ($ Million)
54. Roe Neuroprosthetics Market By Technique 2015-2024 ($ Million)
55. Roe Neuroprosthetics Market By Application 2015-2024 ($ Million)
56. India Neuroprosthetics Market By Type 2015-2024 ($ Million)
57. India Neuroprosthetics Market By Technique 2015-2024 ($ Million)
58. India Neuroprosthetics Market By Application 2015-2024 ($ Million)
59. China Neuroprosthetics Market By Type 2015-2024 ($ Million)
60. China Neuroprosthetics Market By Technique 2015-2024 ($ Million)
61. China Neuroprosthetics Market By Application 2015-2024 ($ Million)
62. Japan Neuroprosthetics Market By Type 2015-2024 ($ Million)
63. Japan Neuroprosthetics Market By Technique 2015-2024 ($ Million)
64. Japan Neuroprosthetics Market By Application 2015-2024 ($ Million)
65. Australia Neuroprosthetics Market By Type 2015-2024 ($ Million)
66. Australia Neuroprosthetics Market By Technique 2015-2024 ($ Million)
67. Australia Neuroprosthetics Market By Application 2015-2024 ($ Million)
68. Roapac Neuroprosthetics Market By Type 2015-2024 ($ Million)
69. Roapac Neuroprosthetics Market By Technique 2015-2024 ($ Million)
70. Roapac Neuroprosthetics Market By Application 2015-2024 ($ Million)
71. Latin America Neuroprosthetics Market By Type 2015-2024 ($ Million)
72. Latin America Neuroprosthetics Market By Technique 2015-2024 ($ Million)
73. Latin America Neuroprosthetics Market By Application 2015-2024 ($ Million)
74. Mena Neuroprosthetics Market By Type 2015-2024 ($ Million)
75. Mena Neuroprosthetics Market By Technique 2015-2024 ($ Million)
76. Mena Neuroprosthetics Market By Application 2015-2024 ($ Million)

List Of Figures:
1. Global Output Neural Prosthetics Market 2015-2024 ($ Million)
2. Global Input Neural Prosthetics Market 2015-2024 ($ Million)
3. Global Spinal Cord Stimulation Market 2015-2024 ($ Million)
4. Global Deep Brain Stimulation Market 2015-2024 ($ Million)
5. Global Vagus Nerve Stimulation Market 2015-2024 ($ Million)
6. Global Sacral Nerve Stimulation Market 2015-2024 ($ Million)
7. Global Transcranial Magnetic Stimulation Market 2015-2024 ($ Million)
8. Global Motor Neuron Disorders Market 2015-2024 ($ Million)
9. Global Physiological Disorders Market 2015-2024 ($ Million)
10. Global Cognitive Disorders Market 2015-2024 ($ Million)
11. United States (U.S.) Neuroprosthetics Market 2015-2024 ($ Million)
12. Canada Neuroprosthetics Market 2015-2024 ($ Million)
13. United Kingdom (UK) Neuroprosthetics Market 2015-2024 ($ Million)
14. France Neuroprosthetics Market 2015-2024 ($ Million)
15. Germany Neuroprosthetics Market 2015-2024 ($ Million)
16. Spain Neuroprosthetics Market 2015-2024 ($ Million)
17. Roe Neuroprosthetics Market 2015-2024 ($ Million)
18. India Neuroprosthetics Market 2015-2024 ($ Million)
19. China Neuroprosthetics Market 2015-2024 ($ Million)
20. Japan Neuroprosthetics Market 2015-2024 ($ Million)
21. Australia Neuroprosthetics Market 2015-2024 ($ Million)
22. Roapac Neuroprosthetics Market 2015-2024 ($ Million)
23. Latin America Neuroprosthetics Market 2015-2024 ($ Million)
24. Mena Neuroprosthetics Market 2015-2024 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Cochlear Limited (Australia)
  • Cyberonics Inc. (U.S.)
  • Livanova Plc (UK)
  • Med-El (Austria)
  • Medtronic Plc (U.S.)
  • NDI Medical Llc (U.S.)
  • Neuropace Inc. (U.S.)
  • Nevro (U.S.)
  • Retina Implant AG (Germany)
  • Second Sight (U.S.)
  • Sonova Holding AG (Switzerland)
  • St. Jude Medical Inc. (U.S.)
  • Zimmer Biomet (U.S.)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll